Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q2 FY2022 Earnings Presentation
10 slides from Phibro Animal Health's earnings presentation, Feb 10, 2022
Slide 1: Phibro Animal Health Corporation Webcast and Conference Call
Phibro Animal Health Corporation Webcast and Conference Call February 10, 2022 Financial Results U.S. toll-free +1-888-330-2022 Fiscal Year 2022 International toll +1-365-977-0051 Second Quarter Ended December 31, 2021 Conference ID: 3927884 February 10, 2022
Slide 2: Important Information
Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to future debt and leverage levels. All statements other than statements of historical or current
Slide 3: Key Themes
Key Themes Second Quarter Adj. EBITDA margin Strongest Second raise to COVID-19 improvement, despite Quarterly Sales in fiscal year 2022 variants remain persistent cost Company history guidance a risk increases Net Sales of $233 Price increases We are raising full The rapid global million is the sin
Slide 4: Financial Performance - Consolidated
Financial Performance - Consolidated Second Quarter, Year-on-Year comparison $ in millions, except per share data Net Sales – increased $26.6 million, or 13%, increase driven YOY by improvement in our Animal Health and Mineral Nutrition Q2 %∆ segments offset slightly by a $0.6 million decline in P
Slide 5: Financial Performance – Animal Health
Financial Performance – Animal Health Second Quarter, Year-on-Year comparison $ in millions Net Sales YOY MFAs and other Q2 %∆ - Increased $10.1 million, or 12%, driven by stronger demand in North and South America, reflecting Animal Health continued recovery from the effects of the pandemic Net
Slide 6: Financial Performance – Other Segments
Financial Performance – Other Segments Second Quarter, Year-on-Year comparison $ in millions YOY Mineral Nutrition Q2 %∆ ￚ Net Sales increased $12.5 million, or 23%, driven by higher Mineral Nutrition average selling prices of trace minerals, correlated with the Net Sales $ 66.7 23% movement of th
Slide 7: Key Capitalization Metrics
Key Capitalization Metrics Second Quarter Highlights $14 million of trailing 12-month free cash flow; operating Free Cash Flow1 cash flow $44 million less capital expenditures of $30 million 3.8x gross leverage ratio; $401 million total debt / Leverage $107 million trailing 12-month adjusted EBITDA
Slide 8: Revised Financial Guidance
Revised Financial Guidance Fiscal Year 2022 $ in millions, except per share data We are revising and raising financial guidance for FY 2022 Guidance net sales, adjusted Net Income and adjusted diluted Previous Revised EPS FY21 H1 FY22 Low High Low High Consolidated Adjusted EBITDA guidance of $1
Slide 9: Q&A
Phibro November 3, 2021 HEALTHY ANIMALS, HEALTHY FOOD. HEALTHY WORLD. * uc net CORPORAT CN
Slide 10: © 2021 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2021 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that
Phibro Animal Health — Q2 FY2022 Earnings Presentation on 6ix